◀ Back to MMP9
MMP9 — OCLN
Text-mined interactions from Literome
Behzadian et al., Invest Ophthalmol Vis Sci 2001
:
Both TGF-beta and
MMP-9 increased the permeability of BRE monolayers and
reduced the levels of the junction protein
occludin
Lohmann et al., Brain Res 2004
:
PAO induced
occludin proteolysis could be
prevented by different
MMP inhibitors
Reijerkerk et al., FASEB J 2006
:
Diapedesis of monocytes is associated with
MMP mediated
occludin disappearance in brain endothelial cells
Huang et al., FASEB J 2009
:
Indeed, the HIV induced decrease in the expression of JAM-A and
occludin was
restored by inhibition of
MMP activity
Liu et al., J Neurochem 2009
(Infarction, Middle Cerebral Artery...) :
Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting
MMP-9 mediated
occludin degradation in focal cerebral ischemia ... Inhibition of
MMP-9 by NBO or MMP-inhibitor, BB1101, significantly
reduced occludin protein loss in ischemic microvessels ... These results suggest that NBO attenuates early BBB disruption, and inhibition of
MMP-9 mediated
occludin degradation is an important mechanism for this protection
Lischper et al., Brain Res 2010
:
MMP inhibition by the metalloproteinase inhibitor GM6001
prevented occludin degradation and reduced the intercellular gap formation
Tu et al., Neurochem Res 2011
(Brain Edema...) :
Our study suggested that baicalin reduces MCAO induced neuronal damage, brain edema and BBB permeability, which might be associated with the inhibition of MMP-9 expression and
MMP-9 mediated
occludin degradation
Liu et al., J Neurosci 2012
(Brain Ischemia...) :
These data indicate that cerebral ischemia initiates two rapid parallel processes,
MMP-2 mediated
occludin degradation and Cav-1 mediated claudin-5 redistribution, to cause BBB disruption at early stroke stages relevant to acute thrombolysis
Jin et al., Exp Neurol 2013
(Brain Ischemia...) :
Our results show that NBO plus minocycline effectively reduces brain injury in transient focal cerebral ischemia with protection due to inhibition on
MMP-2/9 mediated
occludin degradation and attenuation of caspase dependent and independent apoptotic pathways